Skip to main content

Table 1 Patient characteristics (n = 16

From: A standardized approach to treat complex aortic valve endocarditis: a case series

Characteristic Value
Age: median [range] (years) 63 [31–77]
Gender: male; female, n (%) 14 (87.5); 2 (12.5)
Reoperation / PVE (%) 75
Follow-up survivors: median [range] (years) 4.6 [2.3–11.7]
NYHA score: median [range] III [II-IV]
Logarithmic EuroSCORE I: median [range] 40.7 [12.8–68.3]
Microbiology
PVE
• Staphylococcus spp.: 5 CoNS, 1 S. aureus n = 6 (50%)
• Streptococcus spp.: 1 viridans group, 1 S. bovis, 1 S. agalactiae n = 3 (25%)
• Enterococcus spp.: 2 E. faecalis n = 2 (17%)
no micro-organism identified n = 1 (8%)
NVE
• Staphylococcus spp.: S. aureus n = 1 (25%)
• Streptococcus spp.: 2 viridans group n = 2 (50%)
• Enterococcus spp.: E. faecalis n = 1 (25%)
Outcome Value
Cardiopulmonary bypass perfusion time: median [range] (minutes) 358 [186–731]
Aortic cross-clamping time: median [range] (minutes) 266 [107–389]
Intensive care unit stay: median [range] (days) 1.5 [1–21]
Hospital stay: median [range] (days) 55 [29–90]
In-hospital mortality: n (%) 3 (18.8)
30 day mortality: n (%) 2 (12.5)
  1. CoNS coagulase negative staphylococci, COPD chronic obstructive pulmonary disease, e.c.i. e cause ignota, NVE native valve endocarditis, NYHA New York Heart Association, PVE prosthetic valve endocarditis, SD standard deviation